lobbying_activities: 954451

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
954451	5a3ba48b-df90-4a78-9914-44a79c2e0358	Q2	POLICY DIRECTIONS INC.	31747	ADVANCED LIFE SCIENCES	2010	second_quarter	MED	FDA regulatory pathway for new antibiotic medicines. HR 2400, Strategies to Address Antimicrobial Resistance Act, portions related to introduction of and regulatory policy of new antimicrobial candidates.	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE	20000		0	0	2010-07-15T12:53:14.060000-04:00